Skip to main content

Cyclizine Side Effects

Applies to cyclizine: oral tablet, oral tablet chewable.

Important warnings This medicine can cause some serious health issues

Follow all directions on your medicine label and package.

Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Get emergency medical help if you have any of these signs of an allergic reaction while taking cyclizine: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using cyclizine and call your doctor at once if you have:

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to cyclizine: oral tablet, oral tablet chewable.

Nervous system

Paralysis was reported with IV formulations and typically affected the limbs within minutes of administration. This side effect usually resolved within hours following discontinuation of treatment.[Ref]

Other

Dermatologic

Gastrointestinal

Psychiatric

Auditory and visual hallucinations were reported, especially at doses exceeding recommendations.[Ref]

Cardiovascular

Respiratory

Hepatic

Hematologic

Local

Injection site reactions included blisters, erythema, pain, thrombophlebitis, and vein tracking.[Ref]

Hypersensitivity

Anaphylaxis occurred with concomitant propanidid given via IV administration in the same syringe.[Ref]

Metabolic

Musculoskeletal

Ocular

Genitourinary

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics."

2. Cerner Multum, Inc. "Australian Product Information."

3. (2019) "Product Information. Bonine For Kids (cyclizine)." Heritage/Insight Consumer Products

Further information

Cyclizine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.